Program Overview

This activity includes eight 30-minute modules that bring learners up to date on all aspects of cystic fibrosis (CF) treatment and management. Dr. John P. Clancy interviews eight experts in the CF field, each with their own specialization. The individual modules will focus on different areas of CF care, ranging from newborn screening to long-term real world efficacy and safety data. Each module is worth approximately 0.5 CME/CNE credits.

Target Audience

These activities are designed for physicians, nurses, and other healthcare professionals involved in the management of patients with cystic fibrosis.

Educational Objectives

  1. Discuss the importance of newborn screening, accurate diagnosis, genomic evaluation, and early pharmacologic intervention.
  2. Review the current relevant and emerging clinical trial data.
  3. Develop optimal strategies for the CFTR modulated treated patient accurate life-long assessment, monitoring, and management.

Modules

  1. Managing the Under 6-Year-Old Patients, Including Newborn Screening
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.56 Contact Hours
  2. Review of Available Pulmonary Therapeutic Options for Cystic Fibrosis Patients
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.5 Contact Hours
  3. Advances in CFTR Therapeutics for Pediatric Patients with Cystic Fibrosis
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.45 Contact Hours
  4. Cystic Fibrosis: Nutrition & Growth
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.46 Contact Hours
  5. The Importance of the Inter-Professional Team and Shared-Decision Making
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.46 Contact Hours
  6. Genotypes and Phenotypes and Predicting Disease Severity in Patients with CF
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.43 Contact Hours
  7. Efficacy and Safety Data for Combination CFTR Modulator Therapies
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.48 Contact Hours
  8. Longer-Term Real World Efficacy and Safety Data for CFTR Modulators
    0.5 AMA PRA Category 1 Credit™ / CNE: 0.5 Contact Hours

Financial Support

This activity has been supported by an independent educational grant from Vertex Pharmaceuticals Incorporated.

Provider Information

Provided in collaboration with the Elsevier Office of Continuing Medical Education, Elsevier and AcademicCME.

Group visibility: 
Public - accessible to all site users